Expeditors International of Washington
EXPD · NYSE
About EXPD
- Employees
- 19,800
- Headquarters
- Bellevue, Washington
- Listed
- Jun 6, 2005
- Sector
- Industrials
- Industry
- Air Freight & Logistics
- Website
- expeditors.com
EXPD key statistics
- Market cap
- 25.58B
- Price-earnings ratio
- 28.65
- Dividend yield
- 0.82%
- Average volume
- 1.15M
- Volume
- 415.00K
- Open price
- $196.70
- High today
- $199.30
- Low today
- $196.70
- 52 Week high
- $200.66
- 52 Week low
- $116.84
Expeditors International of Washington (EXPD) at a glance
Expeditors International of Washington (EXPD) last traded at $198.41, with a market cap of 25.58B, a price-to-earnings ratio of 28.65 and a dividend yield of 0.82%.
Today the stock has traded between $196.70 and $199.30. The current price is 0.9% above the day's low and 0.4% below its high.
Volume so far is 415.00K shares, below the average of 1.15M shares a day.
Over the past year Expeditors International of Washington has ranged from $116.84 to $200.66, and now sits 97% of the way up that range.
Expeditors International of Washington met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $2.03 per share against an estimate of $1.72.
The average analyst price target is $182.36, 8.1% below the current price, from 13 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy15.4%
- Hold61.5%
- Sell23.1%
- Low
- $101.00
- Now
- $198.41
- High
- $231.00
EXPD earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 14.8% on average.
- Q3 FY24: reported $1.63 per share against an estimate of $1.38
- Q4 FY24: reported $1.68 per share against an estimate of $1.46
- Q1 FY25: reported $1.47 per share against an estimate of $1.40
- Q2 FY25: reported $1.34 per share against an estimate of $1.26
- Q3 FY25: reported $1.64 per share against an estimate of $1.42
- Q4 FY25: reported $1.49 per share against an estimate of $1.49
- Q1 FY26: reported $1.71 per share against an estimate of $1.36
- Q2 FY26: reported $2.03 per share against an estimate of $1.72
EXPD news
- Avi Kapoor
- Avi Kapoor
AstraZeneca, Leidos, Expeditors International And More On CNBC’s ‘Final Trades’
- Press releaseBusiness Wire
Expeditors Reports Second Quarter 2026 EPS of $2.03
- Press releaseBusiness Wire
Expeditors Expands Global Aircraft on Ground Services Amid Rising Demand for Time-Critical Aviation and Aerospace Logistics
- Press releaseBusiness Wire
Expeditors Announces Semi-Annual Cash Dividend of $0.81
- Press releaseBusiness Wire
Expeditors Reports First Quarter 2026 EPS of $1.71
- Piero Cingari
Tech Rebounds On AMD-Meta Deal, Software Stocks Bounce: What's Moving Markets Tuesday?
- Press releaseBusiness Wire
Expeditors Reports Fourth Quarter 2025 EPS of $1.49
Similar companies
Companies in the same industry as Expeditors International of Washington
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.